Literature DB >> 11404004

RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients.

P Seranski1, C Hoff, U Radelof, S Hennig, R Reinhardt, C E Schwartz, N S Heiss, A Poustka.   

Abstract

The human chromosomal band 17p11.2 is a genetically unstable interval. It has been shown to be deleted in patients suffering from Smith-Magenis syndrome. Previous efforts of physical and transcriptional mapping in 17p11.2 and subsequent genomic sequencing of the candidate interval allowed the identification of new genes that might be responsible for the Smith-Magenis syndrome. In this report, one of these genes named RAI1, the human homologue of the mouse Rai1 gene, has been investigated for its contribution to the syndrome. Expression analysis on different human adult and fetal tissues has shown the existence of at least three splice variants. Moreover, the most interesting feature of the gene is the presence of a polymorphic CAG repeat coding for a polyglutamine stretch in the amino terminal domain of the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404004     DOI: 10.1016/s0378-1119(01)00415-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  Role of carotenoids and retinoids during heart development.

Authors:  Ioan Ovidiu Sirbu; Aimée Rodica Chiş; Alexander Radu Moise
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-22       Impact factor: 4.698

2.  Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior.

Authors:  Paulina Carmona-Mora; Katherina Walz
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

3.  Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions.

Authors:  C Dubourg; F Bonnet-Brilhault; A Toutain; C Mignot; A Jacquette; A Dieux; M Gérard; M-P Beaumont-Epinette; S Julia; B Isidor; M Rossi; S Odent; C Bendavid; C Barthélémy; A Verloes; V David
Journal:  Mol Syndromol       Date:  2014-01-07

4.  Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.

Authors:  Weimin Bi; Jiong Yan; Pawe Stankiewicz; Sung-Sup Park; Katherina Walz; Cornelius F Boerkoel; Lorraine Potocki; Lisa G Shaffer; Koen Devriendt; Magorzata J M Nowaczyk; Ken Inoue; James R Lupski
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

5.  RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.

Authors:  S Girirajan; L J Elsas; K Devriendt; S H Elsea
Journal:  J Med Genet       Date:  2005-03-23       Impact factor: 6.318

6.  Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.

Authors:  Weimin Bi; G Mustafa Saifi; Christine J Shaw; Katherina Walz; Patricia Fonseca; Meredith Wilson; Lorraine Potocki; James R Lupski
Journal:  Hum Genet       Date:  2004-09-30       Impact factor: 4.132

7.  RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Cesar P Canales; Lei Cao; Irene C Perez; Anand K Srivastava; Juan I Young; Katherina Walz
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.

Authors:  Thierry Vilboux; Carla Ciccone; Jan K Blancato; Gerald F Cox; Charu Deshpande; Wendy J Introne; William A Gahl; Ann C M Smith; Marjan Huizing
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

9.  RAI14 (retinoic acid induced protein 14) is an F-actin regulator: Lesson from the testis.

Authors:  Xiaojing Qian; Dolores D Mruk; Yan-Ho Cheng; C Yan Cheng
Journal:  Spermatogenesis       Date:  2013-04-01

10.  Gene-network analysis identifies susceptibility genes related to glycobiology in autism.

Authors:  Bert van der Zwaag; Lude Franke; Martin Poot; Ron Hochstenbach; Henk A Spierenburg; Jacob A S Vorstman; Emma van Daalen; Maretha V de Jonge; Nienke E Verbeek; Eva H Brilstra; Ruben van 't Slot; Roel A Ophoff; Michael A van Es; Hylke M Blauw; Jan H Veldink; Jacobine E Buizer-Voskamp; Frits A Beemer; Leonard H van den Berg; Cisca Wijmenga; Hans Kristian Ploos van Amstel; Herman van Engeland; J Peter H Burbach; Wouter G Staal
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.